Replies to post #125971 on Avid Bioservices Inc (CDMO)

[biopharm]

Entdoc... I do agree that there is less and less of that going on. I was only picking on Pfizer because they are the largest BP... biggest market cap close to $200B and I'd have to say that Pfizer would clearly be looking into Peregrine if they want to remain in that #1 rating for the longterm and can't see them passing up on Bavituximab.

Its not just for a single indication... and like any large BP... Bavi combines well on the safety side... and "IF" Peregrine is revealilng any of the "betabodie" data to an interested BP

I can't see them passing up on Peregrine.

May historic data... bring us historic market caps.

GLTA!